vs
Side-by-side financial comparison of CENTRAL PACIFIC FINANCIAL CORP (CPF) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
CENTRAL PACIFIC FINANCIAL CORP is the larger business by last-quarter revenue ($72.9M vs $57.3M, roughly 1.3× RHYTHM PHARMACEUTICALS, INC.). CENTRAL PACIFIC FINANCIAL CORP runs the higher net margin — 28.4% vs -83.0%, a 111.4% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 6.0%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 6.7%).
Central Pacific Bank (CPB) is an American regional commercial bank located throughout the state of Hawaii.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
CPF vs RYTM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $72.9M | $57.3M |
| Net Profit | $20.7M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | — | -82.2% |
| Net Margin | 28.4% | -83.0% |
| Revenue YoY | 6.0% | 36.9% |
| Net Profit YoY | 16.7% | -9.6% |
| EPS (diluted) | $0.78 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $76.3M | $57.3M | ||
| Q3 25 | $74.8M | $51.3M | ||
| Q2 25 | $72.8M | $48.5M | ||
| Q1 25 | $68.8M | $32.7M | ||
| Q4 24 | $58.4M | $41.8M | ||
| Q3 24 | $66.6M | $33.3M | ||
| Q2 24 | $64.0M | $29.1M |
| Q1 26 | $20.7M | — | ||
| Q4 25 | $22.9M | $-47.5M | ||
| Q3 25 | $18.6M | $-52.9M | ||
| Q2 25 | $18.3M | $-46.6M | ||
| Q1 25 | $17.8M | $-49.5M | ||
| Q4 24 | $11.3M | $-43.3M | ||
| Q3 24 | $13.3M | $-43.6M | ||
| Q2 24 | $15.8M | $-32.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% |
| Q1 26 | — | — | ||
| Q4 25 | 37.0% | -82.2% | ||
| Q3 25 | 31.6% | -102.6% | ||
| Q2 25 | 32.8% | -93.4% | ||
| Q1 25 | 32.8% | -143.7% | ||
| Q4 24 | 23.0% | -98.6% | ||
| Q3 24 | 25.6% | -132.0% | ||
| Q2 24 | 32.2% | -139.2% |
| Q1 26 | 28.4% | — | ||
| Q4 25 | 30.0% | -83.0% | ||
| Q3 25 | 24.8% | -103.1% | ||
| Q2 25 | 25.1% | -96.1% | ||
| Q1 25 | 25.8% | -151.4% | ||
| Q4 24 | 19.4% | -103.6% | ||
| Q3 24 | 20.0% | -131.2% | ||
| Q2 24 | 24.7% | -110.9% |
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.85 | $-0.73 | ||
| Q3 25 | $0.69 | $-0.82 | ||
| Q2 25 | $0.67 | $-0.75 | ||
| Q1 25 | $0.65 | $-0.81 | ||
| Q4 24 | $0.42 | $-0.71 | ||
| Q3 24 | $0.49 | $-0.73 | ||
| Q2 24 | $0.58 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $388.9M |
| Total DebtLower is stronger | $76.5M | — |
| Stockholders' EquityBook value | $593.9M | $139.1M |
| Total Assets | $7.5B | $480.2M |
| Debt / EquityLower = less leverage | 0.13× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M |
| Q1 26 | $76.5M | — | ||
| Q4 25 | $76.5M | — | ||
| Q3 25 | $131.5M | — | ||
| Q2 25 | $131.5M | — | ||
| Q1 25 | $131.4M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $156.3M | — | ||
| Q2 24 | $156.2M | — |
| Q1 26 | $593.9M | — | ||
| Q4 25 | $592.6M | $139.1M | ||
| Q3 25 | $588.1M | $148.8M | ||
| Q2 25 | $568.9M | $-11.9M | ||
| Q1 25 | $557.4M | $18.9M | ||
| Q4 24 | $538.4M | $21.7M | ||
| Q3 24 | $543.7M | $11.2M | ||
| Q2 24 | $518.6M | $39.3M |
| Q1 26 | $7.5B | — | ||
| Q4 25 | $7.4B | $480.2M | ||
| Q3 25 | $7.4B | $506.9M | ||
| Q2 25 | $7.4B | $372.7M | ||
| Q1 25 | $7.4B | $386.7M | ||
| Q4 24 | $7.5B | $392.3M | ||
| Q3 24 | $7.4B | $363.6M | ||
| Q2 24 | $7.4B | $381.8M |
| Q1 26 | 0.13× | — | ||
| Q4 25 | 0.13× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.30× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-25.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $97.5M | $-25.4M | ||
| Q3 25 | $22.2M | $-26.6M | ||
| Q2 25 | $34.3M | $-23.3M | ||
| Q1 25 | $20.4M | $-40.4M | ||
| Q4 24 | $90.5M | $-18.8M | ||
| Q3 24 | $21.3M | $-25.2M | ||
| Q2 24 | $25.9M | $-29.1M |
| Q1 26 | — | — | ||
| Q4 25 | $92.3M | — | ||
| Q3 25 | $21.4M | — | ||
| Q2 25 | $32.3M | — | ||
| Q1 25 | $19.6M | — | ||
| Q4 24 | $75.4M | — | ||
| Q3 24 | $15.6M | — | ||
| Q2 24 | $21.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | 121.0% | — | ||
| Q3 25 | 28.6% | — | ||
| Q2 25 | 44.3% | — | ||
| Q1 25 | 28.4% | — | ||
| Q4 24 | 129.2% | — | ||
| Q3 24 | 23.5% | — | ||
| Q2 24 | 33.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 25.8% | — | ||
| Q3 24 | 8.5% | — | ||
| Q2 24 | 7.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.26× | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 7.98× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
